The Specific α-Neurexin Interactor Calsyntenin-3 Promotes Excitatory and Inhibitory Synapse Development-Reference-Cited by-同舟云学术

The Specific α-Neurexin Interactor Calsyntenin-3 Promotes Excitatory and Inhibitory Synapse Development

Published:2013-10 Issue:1 Volume:80 Page:113-128
ISSN:0896-6273
Container-title:Neuron
language:en
Short-container-title:Neuron

Author:

Pettem Katherine L.,Yokomaku Daisaku,Luo Lin,Linhoff Michael W.,Prasad Tuhina,Connor Steven A.,Siddiqui Tabrez J.,Kawabe Hiroshi,Chen Fang,Zhang Ling,Rudenko Gabby,Wang Yu Tian,Brose Nils,Craig Ann Marie

Publisher

Elsevier BV

Subject

General Neuroscience

Reference55 articles.

1. Novel cadherin-related membrane proteins, Alcadeins, enhance the X11-like protein-mediated stabilization of amyloid beta-protein precursor metabolism;Araki;J. Biol. Chem.,2003

2. Coordinated metabolism of Alcadein and amyloid beta-protein precursor regulates FE65-dependent gene transactivation;Araki;J. Biol. Chem.,2004

3. The novel cargo Alcadein induces vesicle association of kinesin-1 motor components and activates axonal transport;Araki;EMBO J.,2007

4. Mapping autism risk loci using genetic linkage and chromosomal rearrangements;Szatmari;Nat. Genet.,2007

5. The emerging role of synaptic cell-adhesion pathways in the pathogenesis of autism spectrum disorders;Betancur;Trends Neurosci.,2009

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Distinct functional domains of Dystroglycan regulate inhibitory synapse formation and maintenance in cerebellar Purkinje cells;2024-08-30

2. Calsyntenin‐1 expression and function in brain tissue of lithium–pilocarpine rat seizure models;Synapse;2024-08-22

3. Suppression of the amyloidogenic metabolism of APP and the accumulation of Aβ by alcadein α in the brain during aging;Scientific Reports;2024-08-09

4. Synaptic cell adhesion molecules contribute to the pathogenesis and progression of fragile X syndrome;Frontiers in Cellular Neuroscience;2024-07-03

5. Dysregulated Cerebrospinal Fluid Proteome of Spinocerebellar Ataxia Type 2 and its Clinical Implications;Movement Disorders;2024-05-20